We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$5.24M
Cap. Flow
-$107M
Cap. Flow %
-61.2%
Top 10 Hldgs %
71.4%
Holding
129
New
32
Increased
17
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$2.18M
2
TDOC icon
Teladoc Health
TDOC
+$2.04M
3
WIFI
Boingo Wireless, Inc.
WIFI
+$1.41M
4
SONM icon
DNA X Inc
SONM
+$1.18M
5
NTNX icon
Nutanix
NTNX
+$1.04M

Top Sells

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$2.53M
2
DZSI
DZS Inc. Common Stock
DZSI
+$1.96M
3
BKNG icon
Booking.com
BKNG
+$1.47M
4
MX icon
Magnachip Semiconductor
MX
+$1.2M
5
MU icon
Micron Technology
MU
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Healthcare 6.35%
3 Industrials 1.7%
4 Consumer Discretionary 0.17%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLE icon
101
State Street Energy Select Sector SPDR ETF
XLE
$39B
– –
-642
Closed -$20K
XLRE icon
102
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
– –
-2,167
Closed -$79K
XLU icon
103
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
– –
-2,644
Closed -$79K
ITCI
104
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-51,200
Closed -$99K
IVAC
105
DELISTED
Intevac Inc
IVAC
– –
-55,964
Closed -$271K
ICPT
106
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-700
Closed -$1K
BNGOW
107
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
– –
-88,446
Closed -$65K
COHR
108
DELISTED
Coherent Inc
COHR
– –
-18,524
Closed -$2.53M
XLNX
109
CALL
DELISTED
Xilinx Inc
XLNX
– –
-30,000
Closed -$169K
DZSI
110
DELISTED
DZS Inc. Common Stock
DZSI
– –
-151,074
Closed -$1.96M
DERM
111
DELISTED
Dermira, Inc.
DERM
– –
-71,372
Closed -$683K
ONCS
112
DELISTED
OncoSec Medical Incorporated
ONCS
– –
-1,784
Closed -$99K
ZGNX
113
PUT
DELISTED
Zogenix, Inc.
ZGNX
– –
-14,500
Closed -$4K
GCVRZ
114
DELISTED
Sanofi Contingent Value Rights
GCVRZ
– –
-28,979
Closed -$15K
1 2 3 4
5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Worth Venture Partners held 129 positions worth $175M, down 2.9% from $181M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Worth Venture Partners withdrew a net $107M in Q3 2019, closing 29 positions and reducing 29 holdings. Its most notable exit was Coherent Inc, an estimated $2.53M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 7.6% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Illumina worth $2.19M.

  • Worth Venture Partners's largest Q3 2019 buy was Illumina: 7,402 shares worth $2.19M.
  • Worth Venture Partners added most to La Jolla Pharmaceutical Company in Q3 2019, an estimated $258K increase.
  • Worth Venture Partners's biggest Q3 2019 reduction was Booking.com, cutting an estimated $1.47M.
  • Worth Venture Partners fully exited Coherent Inc in Q3 2019, selling an estimated $2.53M.
  • Worth Venture Partners's ten largest holdings make up 71% of its $175M portfolio in Q3 2019.
  • Worth Venture Partners opened 32 new positions and closed 29 in Q3 2019.
  • Worth Venture Partners's portfolio value fell 2.9% quarter-over-quarter to $175M.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.